Regulation of tissue‐ and stimulus‐specific cell fate decisions by p53 in vivo
- 18 October 2010
- journal article
- review article
- Published by Wiley in The Journal of Pathology
- Vol. 223 (2) , 127-137
Abstract
The tumour suppressor p53 pathway is often inactivated by multiple mechanisms in the genesis of human cancers. Aberrant cellular proliferation, DNA damage, hypoxia, and ribosomal stress cause activation of the p53 tumour suppressor with multiple possible consequences to the cell: cell death, cell cycle arrest, or senescence. These mechanisms ultimately ensure that the cell does not replicate, and are thus potent tumour suppressor mechanisms. An important question that has eluded the field is how p53 makes these cell fate decisions. This review summarizes the current status of knowledge regarding p53‐mediated stress and tissue‐dependent cell fate decisions in mouse models and human tumours. Copyright © 2010 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.Keywords
This publication has 115 references indexed in Scilit:
- The intestinal epithelium compensates for p53-mediated cell death and guarantees organismal survivalCell Death & Differentiation, 2008
- Oncogenic BRAF Induces Senescence and Apoptosis through Pathways Mediated by the Secreted Protein IGFBP7Cell, 2008
- Life and death decisions by the E2F transcription factorsCurrent Opinion in Cell Biology, 2007
- Short Telomeres Limit Tumor Progression In Vivo by Inducing SenescenceCancer Cell, 2007
- Accumulation of senescent cells in mitotic tissue of aging primatesMechanisms of Ageing and Development, 2007
- A negative feedback signaling network underlies oncogene-induced senescenceCancer Cell, 2006
- Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpointsNature, 2006
- Intrinsic tumour suppressionNature, 2004
- Mutations of the BRAF gene in human cancerNature, 2002
- p53 is required for radiation-induced apoptosis in mouse thymocytesNature, 1993